Literature DB >> 22243960

Structure-based design, synthesis and structure-activity relationships of dibenzosuberyl- and benzoate-substituted tropines as ligands for acetylcholine-binding protein.

Ewald Edink1, Atilla Akdemir, Chimed Jansen, René van Elk, Obbe Zuiderveld, Frans J J de Kanter, Jacqueline E van Muijlwijk-Koezen, August B Smit, Rob Leurs, Iwan J P de Esch.   

Abstract

Using structure-based optimization procedures on in silico hits, dibenzosuberyl- and benzoate substituted tropines were designed as ligands for acetylcholine-binding protein (AChBP). This protein is a homolog to the ligand binding domain of the nicotinic acetylcholine receptor (nAChR). Distinct SAR is observed between two AChBP species variants and between the α7 and α4β2 nAChR subtype. The AChBP species differences are indicative of a difference in accessibility of a ligand-inducible subpocket. Hereby, we have identified a region that can be scrutinized to achieve selectivity for nicotinic receptor subtypes.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22243960     DOI: 10.1016/j.bmcl.2011.12.008

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Discovery, synthesis, biological evaluation and structure-based optimization of novel piperidine derivatives as acetylcholine-binding protein ligands.

Authors:  Jian Shen; Xi-Cheng Yang; Ming-Cheng Yu; Li Xiao; Xun-Jie Zhang; Hui-Jiao Sun; Hao Chen; Guan-Xin Pan; Yu-Rong Yan; Si-Chen Wang; Wei Li; Lu Zhou; Qiong Xie; Lin-Qian Yu; Yong-Hui Wang; Li-Ming Shao
Journal:  Acta Pharmacol Sin       Date:  2016-12-05       Impact factor: 6.150

2.  Identification of novel α7 nicotinic receptor ligands by in silico screening against the crystal structure of a chimeric α7 receptor ligand binding domain.

Authors:  Atilla Akdemir; Ewald Edink; Andrew J Thompson; Sarah C R Lummis; Albert J Kooistra; Chris de Graaf; Iwan J P de Esch
Journal:  Bioorg Med Chem       Date:  2012-07-11       Impact factor: 3.641

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.